DIABETES OBESITY & METABOLISM-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2124678, encodeId=06b021246e8fa, content=确实好杂志，拒稿很快，不耽误。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b88b5516031, createdName=西伯利亚小松鼠, createdTime=Sun Apr 09 23:48:20 CST 2023, time=2023-04-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170577, encodeId=2ec421e057700, content=偏重的研究方向：代谢;糖尿病 经验分享：记录一下～23.11.16投稿 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=082f5193268, createdName=1471fd7fm79暂无昵称, createdTime=Thu Nov 23 19:20:54 CST 2023, time=2023-11-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192848, encodeId=58242192848ee, content=20240301 提交之后就是 Under review 20240312 Awaiting ED Decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c99c9145327, createdName=ms5000002142553829, createdTime=Tue Mar 12 20:14:09 CST 2024, time=2024-03-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179907, encodeId=6dba21e9907d7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：脂肪肝;动物模型;药效 经验分享：12.13投稿，一直显示under review，中间赶上国外圣诞假期，1.4变成waiting editor decision,当天又变成under review，第二天发邮件拒稿。一共3个reviewer, 猜测可能是找了2个review,一个比较负面，另外一个中立。临时又找了第三个，也比较中立。最后还是拒稿了，花了3周左右时间，提的意见还是比较专业的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99162325540, createdName=1225bf88m04暂无昵称, createdTime=Mon Jan 08 09:41:36 CST 2024, time=2024-01-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1238077, encodeId=3efd12380e707, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肥胖;代谢;糖尿病 经验分享：审得挺快的，三周多一点就返回消息了，虽然拒稿了，但是给的审稿意见很中肯详细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c58157848, createdName=ms3000000131313797, createdTime=Thu Aug 11 15:32:24 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561613, encodeId=2cfa56161341, content=审稿速度:1.0 经验分享：投稿到拒稿20天时间转给了另外一个杂志3个审稿人给了非常专业的意见非常好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40462437835, createdName=123cae5bm12(暂无昵称), createdTime=Mon Oct 01 01:16:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089308, encodeId=9d301089308be, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089307, encodeId=c942108930e66, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590844, encodeId=b21d59084484, content=你的怎么样了，同问136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, beContent=136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590897, encodeId=6d4f59089eff, content=是的ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, beContent=ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=730, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27a62542239, createdName=962502598_21725956, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=)]

2023-04-09 西伯利亚小松鼠来自重庆

确实好杂志，拒稿很快，不耽误。

85 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124678, encodeId=06b021246e8fa, content=确实好杂志，拒稿很快，不耽误。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b88b5516031, createdName=西伯利亚小松鼠, createdTime=Sun Apr 09 23:48:20 CST 2023, time=2023-04-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170577, encodeId=2ec421e057700, content=偏重的研究方向：代谢;糖尿病 经验分享：记录一下～23.11.16投稿 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=082f5193268, createdName=1471fd7fm79暂无昵称, createdTime=Thu Nov 23 19:20:54 CST 2023, time=2023-11-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192848, encodeId=58242192848ee, content=20240301 提交之后就是 Under review 20240312 Awaiting ED Decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c99c9145327, createdName=ms5000002142553829, createdTime=Tue Mar 12 20:14:09 CST 2024, time=2024-03-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179907, encodeId=6dba21e9907d7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：脂肪肝;动物模型;药效 经验分享：12.13投稿，一直显示under review，中间赶上国外圣诞假期，1.4变成waiting editor decision,当天又变成under review，第二天发邮件拒稿。一共3个reviewer, 猜测可能是找了2个review,一个比较负面，另外一个中立。临时又找了第三个，也比较中立。最后还是拒稿了，花了3周左右时间，提的意见还是比较专业的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99162325540, createdName=1225bf88m04暂无昵称, createdTime=Mon Jan 08 09:41:36 CST 2024, time=2024-01-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1238077, encodeId=3efd12380e707, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肥胖;代谢;糖尿病 经验分享：审得挺快的，三周多一点就返回消息了，虽然拒稿了，但是给的审稿意见很中肯详细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c58157848, createdName=ms3000000131313797, createdTime=Thu Aug 11 15:32:24 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561613, encodeId=2cfa56161341, content=审稿速度:1.0 经验分享：投稿到拒稿20天时间转给了另外一个杂志3个审稿人给了非常专业的意见非常好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40462437835, createdName=123cae5bm12(暂无昵称), createdTime=Mon Oct 01 01:16:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089308, encodeId=9d301089308be, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089307, encodeId=c942108930e66, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590844, encodeId=b21d59084484, content=你的怎么样了，同问136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, beContent=136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590897, encodeId=6d4f59089eff, content=是的ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, beContent=ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=730, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27a62542239, createdName=962502598_21725956, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=)]

2023-11-23 1471fd7fm79暂无昵称来自辽宁省

偏重的研究方向：代谢;糖尿病
经验分享：记录一下～23.11.16投稿 under review

46 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124678, encodeId=06b021246e8fa, content=确实好杂志，拒稿很快，不耽误。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b88b5516031, createdName=西伯利亚小松鼠, createdTime=Sun Apr 09 23:48:20 CST 2023, time=2023-04-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170577, encodeId=2ec421e057700, content=偏重的研究方向：代谢;糖尿病 经验分享：记录一下～23.11.16投稿 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=082f5193268, createdName=1471fd7fm79暂无昵称, createdTime=Thu Nov 23 19:20:54 CST 2023, time=2023-11-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192848, encodeId=58242192848ee, content=20240301 提交之后就是 Under review 20240312 Awaiting ED Decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c99c9145327, createdName=ms5000002142553829, createdTime=Tue Mar 12 20:14:09 CST 2024, time=2024-03-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179907, encodeId=6dba21e9907d7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：脂肪肝;动物模型;药效 经验分享：12.13投稿，一直显示under review，中间赶上国外圣诞假期，1.4变成waiting editor decision,当天又变成under review，第二天发邮件拒稿。一共3个reviewer, 猜测可能是找了2个review,一个比较负面，另外一个中立。临时又找了第三个，也比较中立。最后还是拒稿了，花了3周左右时间，提的意见还是比较专业的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99162325540, createdName=1225bf88m04暂无昵称, createdTime=Mon Jan 08 09:41:36 CST 2024, time=2024-01-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1238077, encodeId=3efd12380e707, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肥胖;代谢;糖尿病 经验分享：审得挺快的，三周多一点就返回消息了，虽然拒稿了，但是给的审稿意见很中肯详细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c58157848, createdName=ms3000000131313797, createdTime=Thu Aug 11 15:32:24 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561613, encodeId=2cfa56161341, content=审稿速度:1.0 经验分享：投稿到拒稿20天时间转给了另外一个杂志3个审稿人给了非常专业的意见非常好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40462437835, createdName=123cae5bm12(暂无昵称), createdTime=Mon Oct 01 01:16:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089308, encodeId=9d301089308be, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089307, encodeId=c942108930e66, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590844, encodeId=b21d59084484, content=你的怎么样了，同问136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, beContent=136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590897, encodeId=6d4f59089eff, content=是的ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, beContent=ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=730, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27a62542239, createdName=962502598_21725956, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=)]

2024-03-12 ms5000002142553829 来自江苏省

20240301 提交之后就是 Under review
20240312 Awaiting ED Decision

13 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124678, encodeId=06b021246e8fa, content=确实好杂志，拒稿很快，不耽误。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b88b5516031, createdName=西伯利亚小松鼠, createdTime=Sun Apr 09 23:48:20 CST 2023, time=2023-04-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170577, encodeId=2ec421e057700, content=偏重的研究方向：代谢;糖尿病 经验分享：记录一下～23.11.16投稿 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=082f5193268, createdName=1471fd7fm79暂无昵称, createdTime=Thu Nov 23 19:20:54 CST 2023, time=2023-11-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192848, encodeId=58242192848ee, content=20240301 提交之后就是 Under review 20240312 Awaiting ED Decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c99c9145327, createdName=ms5000002142553829, createdTime=Tue Mar 12 20:14:09 CST 2024, time=2024-03-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179907, encodeId=6dba21e9907d7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：脂肪肝;动物模型;药效 经验分享：12.13投稿，一直显示under review，中间赶上国外圣诞假期，1.4变成waiting editor decision,当天又变成under review，第二天发邮件拒稿。一共3个reviewer, 猜测可能是找了2个review,一个比较负面，另外一个中立。临时又找了第三个，也比较中立。最后还是拒稿了，花了3周左右时间，提的意见还是比较专业的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99162325540, createdName=1225bf88m04暂无昵称, createdTime=Mon Jan 08 09:41:36 CST 2024, time=2024-01-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1238077, encodeId=3efd12380e707, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肥胖;代谢;糖尿病 经验分享：审得挺快的，三周多一点就返回消息了，虽然拒稿了，但是给的审稿意见很中肯详细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c58157848, createdName=ms3000000131313797, createdTime=Thu Aug 11 15:32:24 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561613, encodeId=2cfa56161341, content=审稿速度:1.0 经验分享：投稿到拒稿20天时间转给了另外一个杂志3个审稿人给了非常专业的意见非常好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40462437835, createdName=123cae5bm12(暂无昵称), createdTime=Mon Oct 01 01:16:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089308, encodeId=9d301089308be, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089307, encodeId=c942108930e66, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590844, encodeId=b21d59084484, content=你的怎么样了，同问136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, beContent=136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590897, encodeId=6d4f59089eff, content=是的ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, beContent=ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=730, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27a62542239, createdName=962502598_21725956, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=)]

2024-01-08 1225bf88m04暂无昵称来自北京

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：脂肪肝;动物模型;药效
经验分享：12.13投稿，一直显示under review，中间赶上国外圣诞假期，1.4变成waiting editor decision,当天又变成under review，第二天发邮件拒稿。一共3个reviewer, 猜测可能是找了2个review,一个比较负面，另外一个中立。临时又找了第三个，也比较中立。最后还是拒稿了，花了3周左右时间，提的意见还是比较专业的。

25 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124678, encodeId=06b021246e8fa, content=确实好杂志，拒稿很快，不耽误。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b88b5516031, createdName=西伯利亚小松鼠, createdTime=Sun Apr 09 23:48:20 CST 2023, time=2023-04-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170577, encodeId=2ec421e057700, content=偏重的研究方向：代谢;糖尿病 经验分享：记录一下～23.11.16投稿 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=082f5193268, createdName=1471fd7fm79暂无昵称, createdTime=Thu Nov 23 19:20:54 CST 2023, time=2023-11-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192848, encodeId=58242192848ee, content=20240301 提交之后就是 Under review 20240312 Awaiting ED Decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c99c9145327, createdName=ms5000002142553829, createdTime=Tue Mar 12 20:14:09 CST 2024, time=2024-03-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179907, encodeId=6dba21e9907d7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：脂肪肝;动物模型;药效 经验分享：12.13投稿，一直显示under review，中间赶上国外圣诞假期，1.4变成waiting editor decision,当天又变成under review，第二天发邮件拒稿。一共3个reviewer, 猜测可能是找了2个review,一个比较负面，另外一个中立。临时又找了第三个，也比较中立。最后还是拒稿了，花了3周左右时间，提的意见还是比较专业的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99162325540, createdName=1225bf88m04暂无昵称, createdTime=Mon Jan 08 09:41:36 CST 2024, time=2024-01-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1238077, encodeId=3efd12380e707, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肥胖;代谢;糖尿病 经验分享：审得挺快的，三周多一点就返回消息了，虽然拒稿了，但是给的审稿意见很中肯详细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c58157848, createdName=ms3000000131313797, createdTime=Thu Aug 11 15:32:24 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561613, encodeId=2cfa56161341, content=审稿速度:1.0 经验分享：投稿到拒稿20天时间转给了另外一个杂志3个审稿人给了非常专业的意见非常好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40462437835, createdName=123cae5bm12(暂无昵称), createdTime=Mon Oct 01 01:16:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089308, encodeId=9d301089308be, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089307, encodeId=c942108930e66, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590844, encodeId=b21d59084484, content=你的怎么样了，同问136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, beContent=136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590897, encodeId=6d4f59089eff, content=是的ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, beContent=ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=730, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27a62542239, createdName=962502598_21725956, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=)]

2022-08-11 ms3000000131313797

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：肥胖;代谢;糖尿病
经验分享：审得挺快的，三周多一点就返回消息了，虽然拒稿了，但是给的审稿意见很中肯详细

153 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124678, encodeId=06b021246e8fa, content=确实好杂志，拒稿很快，不耽误。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b88b5516031, createdName=西伯利亚小松鼠, createdTime=Sun Apr 09 23:48:20 CST 2023, time=2023-04-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170577, encodeId=2ec421e057700, content=偏重的研究方向：代谢;糖尿病 经验分享：记录一下～23.11.16投稿 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=082f5193268, createdName=1471fd7fm79暂无昵称, createdTime=Thu Nov 23 19:20:54 CST 2023, time=2023-11-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192848, encodeId=58242192848ee, content=20240301 提交之后就是 Under review 20240312 Awaiting ED Decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c99c9145327, createdName=ms5000002142553829, createdTime=Tue Mar 12 20:14:09 CST 2024, time=2024-03-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179907, encodeId=6dba21e9907d7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：脂肪肝;动物模型;药效 经验分享：12.13投稿，一直显示under review，中间赶上国外圣诞假期，1.4变成waiting editor decision,当天又变成under review，第二天发邮件拒稿。一共3个reviewer, 猜测可能是找了2个review,一个比较负面，另外一个中立。临时又找了第三个，也比较中立。最后还是拒稿了，花了3周左右时间，提的意见还是比较专业的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99162325540, createdName=1225bf88m04暂无昵称, createdTime=Mon Jan 08 09:41:36 CST 2024, time=2024-01-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1238077, encodeId=3efd12380e707, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肥胖;代谢;糖尿病 经验分享：审得挺快的，三周多一点就返回消息了，虽然拒稿了，但是给的审稿意见很中肯详细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c58157848, createdName=ms3000000131313797, createdTime=Thu Aug 11 15:32:24 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561613, encodeId=2cfa56161341, content=审稿速度:1.0 经验分享：投稿到拒稿20天时间转给了另外一个杂志3个审稿人给了非常专业的意见非常好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40462437835, createdName=123cae5bm12(暂无昵称), createdTime=Mon Oct 01 01:16:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089308, encodeId=9d301089308be, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089307, encodeId=c942108930e66, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590844, encodeId=b21d59084484, content=你的怎么样了，同问136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, beContent=136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590897, encodeId=6d4f59089eff, content=是的ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, beContent=ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=730, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27a62542239, createdName=962502598_21725956, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=)]

2018-10-01 123cae5bm12(暂无昵称)

审稿速度:1.0
经验分享：投稿到拒稿20天时间转给了另外一个杂志3个审稿人给了非常专业的意见非常好的杂志

841 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124678, encodeId=06b021246e8fa, content=确实好杂志，拒稿很快，不耽误。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b88b5516031, createdName=西伯利亚小松鼠, createdTime=Sun Apr 09 23:48:20 CST 2023, time=2023-04-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170577, encodeId=2ec421e057700, content=偏重的研究方向：代谢;糖尿病 经验分享：记录一下～23.11.16投稿 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=082f5193268, createdName=1471fd7fm79暂无昵称, createdTime=Thu Nov 23 19:20:54 CST 2023, time=2023-11-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192848, encodeId=58242192848ee, content=20240301 提交之后就是 Under review 20240312 Awaiting ED Decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c99c9145327, createdName=ms5000002142553829, createdTime=Tue Mar 12 20:14:09 CST 2024, time=2024-03-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179907, encodeId=6dba21e9907d7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：脂肪肝;动物模型;药效 经验分享：12.13投稿，一直显示under review，中间赶上国外圣诞假期，1.4变成waiting editor decision,当天又变成under review，第二天发邮件拒稿。一共3个reviewer, 猜测可能是找了2个review,一个比较负面，另外一个中立。临时又找了第三个，也比较中立。最后还是拒稿了，花了3周左右时间，提的意见还是比较专业的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99162325540, createdName=1225bf88m04暂无昵称, createdTime=Mon Jan 08 09:41:36 CST 2024, time=2024-01-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1238077, encodeId=3efd12380e707, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肥胖;代谢;糖尿病 经验分享：审得挺快的，三周多一点就返回消息了，虽然拒稿了，但是给的审稿意见很中肯详细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c58157848, createdName=ms3000000131313797, createdTime=Thu Aug 11 15:32:24 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561613, encodeId=2cfa56161341, content=审稿速度:1.0 经验分享：投稿到拒稿20天时间转给了另外一个杂志3个审稿人给了非常专业的意见非常好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40462437835, createdName=123cae5bm12(暂无昵称), createdTime=Mon Oct 01 01:16:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089308, encodeId=9d301089308be, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089307, encodeId=c942108930e66, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590844, encodeId=b21d59084484, content=你的怎么样了，同问136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, beContent=136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590897, encodeId=6d4f59089eff, content=是的ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, beContent=ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=730, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27a62542239, createdName=962502598_21725956, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=)]

2021-12-29 乌云背后的幸福线

期刊发送邮件中包括哪几个方面的内容？

559 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124678, encodeId=06b021246e8fa, content=确实好杂志，拒稿很快，不耽误。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b88b5516031, createdName=西伯利亚小松鼠, createdTime=Sun Apr 09 23:48:20 CST 2023, time=2023-04-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170577, encodeId=2ec421e057700, content=偏重的研究方向：代谢;糖尿病 经验分享：记录一下～23.11.16投稿 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=082f5193268, createdName=1471fd7fm79暂无昵称, createdTime=Thu Nov 23 19:20:54 CST 2023, time=2023-11-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192848, encodeId=58242192848ee, content=20240301 提交之后就是 Under review 20240312 Awaiting ED Decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c99c9145327, createdName=ms5000002142553829, createdTime=Tue Mar 12 20:14:09 CST 2024, time=2024-03-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179907, encodeId=6dba21e9907d7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：脂肪肝;动物模型;药效 经验分享：12.13投稿，一直显示under review，中间赶上国外圣诞假期，1.4变成waiting editor decision,当天又变成under review，第二天发邮件拒稿。一共3个reviewer, 猜测可能是找了2个review,一个比较负面，另外一个中立。临时又找了第三个，也比较中立。最后还是拒稿了，花了3周左右时间，提的意见还是比较专业的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99162325540, createdName=1225bf88m04暂无昵称, createdTime=Mon Jan 08 09:41:36 CST 2024, time=2024-01-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1238077, encodeId=3efd12380e707, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肥胖;代谢;糖尿病 经验分享：审得挺快的，三周多一点就返回消息了，虽然拒稿了，但是给的审稿意见很中肯详细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c58157848, createdName=ms3000000131313797, createdTime=Thu Aug 11 15:32:24 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561613, encodeId=2cfa56161341, content=审稿速度:1.0 经验分享：投稿到拒稿20天时间转给了另外一个杂志3个审稿人给了非常专业的意见非常好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40462437835, createdName=123cae5bm12(暂无昵称), createdTime=Mon Oct 01 01:16:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089308, encodeId=9d301089308be, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089307, encodeId=c942108930e66, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590844, encodeId=b21d59084484, content=你的怎么样了，同问136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, beContent=136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590897, encodeId=6d4f59089eff, content=是的ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, beContent=ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=730, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27a62542239, createdName=962502598_21725956, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=)]

2021-12-29 小动量

期刊给我发了一封信，但我看不懂怎么办？

656 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124678, encodeId=06b021246e8fa, content=确实好杂志，拒稿很快，不耽误。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b88b5516031, createdName=西伯利亚小松鼠, createdTime=Sun Apr 09 23:48:20 CST 2023, time=2023-04-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170577, encodeId=2ec421e057700, content=偏重的研究方向：代谢;糖尿病 经验分享：记录一下～23.11.16投稿 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=082f5193268, createdName=1471fd7fm79暂无昵称, createdTime=Thu Nov 23 19:20:54 CST 2023, time=2023-11-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192848, encodeId=58242192848ee, content=20240301 提交之后就是 Under review 20240312 Awaiting ED Decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c99c9145327, createdName=ms5000002142553829, createdTime=Tue Mar 12 20:14:09 CST 2024, time=2024-03-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179907, encodeId=6dba21e9907d7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：脂肪肝;动物模型;药效 经验分享：12.13投稿，一直显示under review，中间赶上国外圣诞假期，1.4变成waiting editor decision,当天又变成under review，第二天发邮件拒稿。一共3个reviewer, 猜测可能是找了2个review,一个比较负面，另外一个中立。临时又找了第三个，也比较中立。最后还是拒稿了，花了3周左右时间，提的意见还是比较专业的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99162325540, createdName=1225bf88m04暂无昵称, createdTime=Mon Jan 08 09:41:36 CST 2024, time=2024-01-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1238077, encodeId=3efd12380e707, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肥胖;代谢;糖尿病 经验分享：审得挺快的，三周多一点就返回消息了，虽然拒稿了，但是给的审稿意见很中肯详细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c58157848, createdName=ms3000000131313797, createdTime=Thu Aug 11 15:32:24 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561613, encodeId=2cfa56161341, content=审稿速度:1.0 经验分享：投稿到拒稿20天时间转给了另外一个杂志3个审稿人给了非常专业的意见非常好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40462437835, createdName=123cae5bm12(暂无昵称), createdTime=Mon Oct 01 01:16:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089308, encodeId=9d301089308be, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089307, encodeId=c942108930e66, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590844, encodeId=b21d59084484, content=你的怎么样了，同问136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, beContent=136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590897, encodeId=6d4f59089eff, content=是的ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, beContent=ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=730, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27a62542239, createdName=962502598_21725956, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=)]

2020-05-14 ugly

你的怎么样了，同问136****7651 2018-04-26 00:00:00 发表:
我想咨询下投稿后就会立即显示under review吗?谢谢!

136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!

687 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124678, encodeId=06b021246e8fa, content=确实好杂志，拒稿很快，不耽误。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b88b5516031, createdName=西伯利亚小松鼠, createdTime=Sun Apr 09 23:48:20 CST 2023, time=2023-04-09, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2170577, encodeId=2ec421e057700, content=偏重的研究方向：代谢;糖尿病 经验分享：记录一下～23.11.16投稿 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=082f5193268, createdName=1471fd7fm79暂无昵称, createdTime=Thu Nov 23 19:20:54 CST 2023, time=2023-11-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2192848, encodeId=58242192848ee, content=20240301 提交之后就是 Under review 20240312 Awaiting ED Decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c99c9145327, createdName=ms5000002142553829, createdTime=Tue Mar 12 20:14:09 CST 2024, time=2024-03-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2179907, encodeId=6dba21e9907d7, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：脂肪肝;动物模型;药效 经验分享：12.13投稿，一直显示under review，中间赶上国外圣诞假期，1.4变成waiting editor decision,当天又变成under review，第二天发邮件拒稿。一共3个reviewer, 猜测可能是找了2个review,一个比较负面，另外一个中立。临时又找了第三个，也比较中立。最后还是拒稿了，花了3周左右时间，提的意见还是比较专业的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99162325540, createdName=1225bf88m04暂无昵称, createdTime=Mon Jan 08 09:41:36 CST 2024, time=2024-01-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1238077, encodeId=3efd12380e707, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肥胖;代谢;糖尿病 经验分享：审得挺快的，三周多一点就返回消息了，虽然拒稿了，但是给的审稿意见很中肯详细, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20c58157848, createdName=ms3000000131313797, createdTime=Thu Aug 11 15:32:24 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561613, encodeId=2cfa56161341, content=审稿速度:1.0 经验分享：投稿到拒稿20天时间转给了另外一个杂志3个审稿人给了非常专业的意见非常好的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=841, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40462437835, createdName=123cae5bm12(暂无昵称), createdTime=Mon Oct 01 01:16:00 CST 2018, time=2018-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089308, encodeId=9d301089308be, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089307, encodeId=c942108930e66, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=656, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590844, encodeId=b21d59084484, content=你的怎么样了，同问136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, beContent=136****7651 2018-04-26 00:00:00 发表: 我想咨询下投稿后就会立即显示under review吗?谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=687, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b492576, createdName=ugly, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590897, encodeId=6d4f59089eff, content=是的ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, beContent=ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=730, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27a62542239, createdName=962502598_21725956, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=)]

2020-05-15 962502598_21725956

是的ugly 2020-05-14 00:00:00 发表:
投稿后是不是立即显示under review？

ugly 2020-05-14 00:00:00 发表: 投稿后是不是立即显示under review？

730 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务